The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Structural insights into the human D1 and D2 dopamine receptor signaling complexes
Open accessAbstract
SUMMARY The D1- and D2-dopamine receptors (D1R and D2R), which signal through Gs and Gi, respectively, represent the principal stimulatory and inhibitory dopamine receptors in the central nervous system. D1R and D2R also represent the main therapeutic targets for Parkinson’s disease, schizophrenia, and many other neuropsychiatric disorders, and insight into their signaling is essential for understanding both therapeutic and side effects of dopaminergic drugs. Here, we report four cryoelectron microscopy (cryo-EM) structures of D1R-Gs and D2R-Gi signaling complexes with selective and non-selective dopamine agonists, including two currently used anti-Parkinson’s disease drugs, apomorphine and bromocriptine. These structures, together with mutagenesis studies, reveal the conserved binding mode of dopamine agonists, the unique pocket topology underlying ligand selectivity, the conformational changes in receptor activation, and potential structural determinants for G protein-coupling selectivity. These results provide both a molecular understanding of dopamine signaling and multiple structural templates for drug design targeting the dopaminergic system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115 · cited 3×
“MolProbity: all-atom structure validation for macromolecular crystallography.”
InfluentialUCSF ChimeraX: Structure visualization for researchers, educators, and developers
Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2021) · Protein Science · doi:10.1002/pro.3943 · Cited by 9,514
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Automated electron microscope tomography using robust prediction of specimen movements
Mastronarde, D. N. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.07.007 · Cited by 5,336
CTFFIND4: Fast and accurate defocus estimation from electron micrographs
Rohou, A., & Grigorieff, N. (2015) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.08.008 · Cited by 4,913
New tools for automated high-resolution cryo-EM structure determination in RELION-3
Zivanov, J., Nakane, T., Forsberg, B. O., Kimanius, D., Hagen, W. J., Lindahl, E., & Scheres, S. H. (2018) · eLife · doi:10.7554/elife.42166 · Cited by 4,621
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Gctf: Real-time CTF determination and correction
Zhang, K. (2016) · Journal of Structural Biology · doi:10.1016/j.jsb.2015.11.003 · Cited by 3,537
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
DeepEMhancer: a deep learning solution for cryo-EM volume post-processing
Sanchez-Garcia, R., Gomez-Blanco, J., Cuervo, A., Carazo, J. M., Sorzano, C. O. S., & Vargas, J. (2021) · Communications Biology · doi:10.1038/s42003-021-02399-1 · Cited by 1,343
The brain on drugs: from reward to addiction
Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Self-citationStructure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Chien, E. Y. T., Liu, W., Zhao, Q., Katritch, V., Won Han, G., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., et al. (2010) · Science · doi:10.1126/science.1197410 · Cited by 1,128
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
Vijayraghavan, S., Wang, M., Birnbaum, S. G., Williams, G. V., & Arnsten, A. F. T. (2007) · Nature Neuroscience · doi:10.1038/nn1846 · Cited by 1,013 · cited 1×
“Aberrant D1R and D2R signaling has been associated with many neuropsychiatric diseases including Parkinson’s disease (PD), schizophrenia, various types of cognitive impairment, attention-deficit hyperactivity disorder (ADHD), drug abuse, and autism (Abi-Dargham et al., 2002; Beaulieu and Gainetdinov, 2011; Beninger an…”
Dopamine and drug addiction: the nucleus accumbens shell connection
Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M. A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V., & Lecca, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.032 · Cited by 935
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755
Self-citationPrefrontal Dopamine D1Receptors and Working Memory in Schizophrenia
Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.-R., Keilp, J., Kochan, L., Van Heertum, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03708.2002 · Cited by 724
Alternative splicing directs the expression of two D2 dopamine receptor isoforms
Giros, B., Sokoloff, P., Martres, M.-P., Riou, J.-F., Emorine, L. J., & Schwartz, J.-C. (1989) · Nature · doi:10.1038/342923a0 · Cited by 685
Structure of the µ-opioid receptor–Gi protein complex
Koehl, A., Hu, H., Maeda, S., Zhang, Y., Qu, Q., Paggi, J. M., Latorraca, N. R., Hilger, D., Dawson, R., Matile, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0219-7 · Cited by 658
Self-citationMultiple D2 dopamine receptors produced by alternative RNA splicing
Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641
Changes in cortical dopamine D1 receptor binding associated with cognitive training
McNab, F., Varrone, A., Farde, L., Jucaite, A., Bystritsky, P., Forssberg, H., & Klingberg, T. (2009) · Science · doi:10.1126/science.1166102 · Cited by 545
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody
Ring, A. M., Manglik, A., Kruse, A. C., Enos, M. D., Weis, W. I., Garcia, K. C., & Kobilka, B. K. (2013) · Nature · doi:10.1038/nature12572 · Cited by 491
Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
Wang, S., Che, T., Levit, A., Shoichet, B. K., Wacker, D., & Roth, B. L. (2018) · Nature · doi:10.1038/nature25758 · Cited by 483
Self-citationFusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.04.010 · Cited by 461
Serial Femtosecond Crystallography of G Protein–Coupled Receptors
Liu, W., Wacker, D., Gati, C., Han, G. W., James, D., Wang, D., Nelson, G., Weierstall, U., Katritch, V., Barty, A., et al. (2013) · Science · doi:10.1126/science.1244142 · Cited by 455
Structure of the adenosine A2A receptor bound to an engineered G protein
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W., & Tate, C. G. (2016) · Nature · doi:10.1038/nature18966 · Cited by 435
Lemon, N., & Manahan-Vaughan, D. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1454-06.2006 · Cited by 345
Dopamine D1-like Receptors and Reward-related Incentive Learning
Beninger, R. (1998) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(97)00019-5 · Cited by 298
D4dopamine receptor high-resolution structures enable the discovery of selective agonists
Wang, S., Wacker, D., Levit, A., Che, T., Betz, R. M., McCorvy, J. D., Venkatakrishnan, A. J., Huang, X.-P., Dror, R. O., Shoichet, B. K., et al. (2017) · Science · doi:10.1126/science.aan5468 · Cited by 261
Self-citationCryo-EM structure of human rhodopsin bound to an inhibitory G protein
Kang, Y., Kuybeda, O., de Waal, P. W., Mukherjee, S., Van Eps, N., Dutka, P., Zhou, X. E., Bartesaghi, A., Erramilli, S., Morizumi, T., et al. (2018) · Nature · doi:10.1038/s41586-018-0215-y · Cited by 261
Self-citationCryo-EM structure of the adenosine A2A receptor coupled to an engineered heterotrimeric G protein
García-Nafría, J., Lee, Y., Bai, X., Carpenter, B., & Tate, C. G. (2018) · eLife · doi:10.7554/elife.35946 · Cited by 253
Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex
Xing, C., Zhuang, Y., Xu, T.-H., Feng, Z., Zhou, X. E., Chen, M., Wang, L., Meng, X., Xue, Y., Wang, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.007 · Cited by 239
Self-citationNanobody stabilization of G protein-coupled receptor conformational states
Steyaert, J., & Kobilka, B. K. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.06.011 · Cited by 234
Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy
Andersen, P. H., & Jansen, J. A. (1990) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(90)90194-3 · Cited by 234
Structure of a D2 dopamine receptor–G-protein complex in a lipid membrane
Yin, J., Chen, K.-Y. M., Clark, M. J., Hijazi, M., Kumari, P., Bai, X.-C., Sunahara, R. K., Barth, P., & Rosenbaum, D. M. (2020) · Nature · doi:10.1038/s41586-020-2379-5 · Cited by 214
Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist
Masureel, M., Zou, Y., Picard, L.-P., van der Westhuizen, E., Mahoney, J. P., Rodrigues, J. P. G. L. M., Mildorf, T. J., Dror, R. O., Shaw, D. E., Bouvier, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0145-x · Cited by 194
Self-citationMu Opioid Receptor-Gi Protein Complex: 6dde
Koehl, A., Hu, H., Maeda, S., Manglik, A., Zhang, Y., Kobilka, B. K., Skiniotis, G., & Weis, W. I. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6dde/pdb · Cited by 172
Self-citationLigand recognition and allosteric regulation of DRD1-Gs signaling complexes
Xiao, P., Yan, W., Gou, L., Zhong, Y.-N., Kong, L., Wu, C., Wen, X., Yuan, Y., Cao, S., Qu, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.028 · Cited by 159
Self-citationEpinephrine and Norepinephrine Act as Potent Agonists at the Recombinant Human Dopamine D4 Receptor
Lanau, F., Zenner, M.-T., Civelli, O., & Hartman, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020804.x · Cited by 136
Liang, Y.-L., Zhao, P., Draper-Joyce, C. J., Baltos, J., Glukhova, A., Truong, T. T., May, L. T., Christopoulos, A., Wootten, D. L., Sexton, P. M., et al. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00017 · Cited by 126
Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
Fan, L., Tan, L., Chen, Z., Qi, J., Nie, F., Luo, Z., Cheng, J., & Wang, S. (2020) · Nature Communications · doi:10.1038/s41467-020-14884-y · Cited by 126
Zhuang, Y., Liu, H., Zhou, X. E., Verma, R. K., de Waal, P. W., Jang, W., Xu, T.-H., Wang, L., Meng, X. M., Zhao, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14728-9 · Cited by 112
Self-citationHeymann, J. B. (2017) · Protein Science · doi:10.1002/pro.3293 · Cited by 109
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines
Neumeyer, J. L. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02008-9 · Cited by 93
Sánchez‐Soto, M., Bonifazi, A., Cai, N. S., Ellenberger, M. P., Newman, A. H., Ferré, S., & Yano, H. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.101808 · Cited by 87
Bromocriptine treatment in Parkinson's disease.
Parkes, J. D., MARSDEN, C. D., Donaldson, I. M., et al. (1976) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.2.184 · Cited by 76
Polypharmacology of dopamine receptor ligands
Butini, S., Nikolic, K. M., Kassel, S., Brückmann, H., Filipić, S., Agbaba, D. D., Gemma, S., Brogi, S., Brindisi, M., Campiani, G., et al. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.011 · Cited by 75
The structural basis of the dominant negative phenotype of the Gαi1β1γ2 G203A/A326S heterotrimer
Liu, P., Jia, M.-Z., Zhou, X. E., de Waal, P. W., Dickson, B. M., Liu, B., Hou, L., Yin, Y., Kang, Y., Shi, Y., et al. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.69 · Cited by 72
Self-citationAminergic GPCR–Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data
Vass, M., Podlewska, S., de Esch, I. J. P., Bojarski, A. J., Leurs, R., Kooistra, A. J., & de Graaf, C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00836 · Cited by 72
Hall, A., Provins, L., & Valade, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01767 · Cited by 72
Conroy, J., Free, R. B., & Sibley, D. R. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00020 · Cited by 68
Keyser, J. D., Backer, J. D., Wilczak, N., & Herroelen, L. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00232-4 · Cited by 42
Lee, S. M., Kant, A., Blake, D. C., Murthy, V., Boyd, K. N., Wyrick, S. D., & Mailman, R. B. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.042 · Cited by 41
Kostrzewa, R. M., Wydra, K., Filip, M., Crawford, C. A., McDougall, S. A., Brown, R. W., Borroto‐Escuela, D. O., Fuxé, K., & Gainetdinov, R. R. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.247981 · Cited by 22
Cited by
Structure-based discovery of nonhallucinogenic psychedelic analogs
Cao, D., Yu, J., Wang, H., Luo, Z., Liu, X., He, L., Qi, J., Fan, L., Tang, L., Chen, Z., et al. (2022) · Science · doi:10.1126/science.abl8615 · Cited by 312
The neural basis of psychedelic action
Kwan, A. C., Olson, D. E., Preller, K. H., & Roth, B. L. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01177-4 · Cited by 302
Self-citationMolecular recognition of morphine and fentanyl by the human μ-opioid receptor
Zhuang, Y., Wang, Y., He, B., He, X., Zhou, X. E., Guo, S., Rao, Q., Yang, J., Liu, J., Zhou, Q., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.041 · Cited by 273
Self-citationAutomatic and accurate ligand structure determination guided by cryo-electron microscopy maps
Muenks, A., Zepeda, S., Zhou, G., Veesler, D., & DiMaio, F. (2023) · Nature Communications · doi:10.1038/s41467-023-36732-5 · Cited by 28
Mirror-Image L-DNA Aptamers Enable Stable In Vivo Dopamine Sensing
Liu, Y., Jin, Y., Zhu, F., Li, X., Ma, C., Sun, Z., Yao, Y., Song, K., Mao, L., & Jiang, Y. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c22265 · Cited by 17
Self-citation
Metadata
- Authors
- Zhuang, Y., Xu, P., Mao, C., Wang, L., Krumm, B., Zhou, X. E., Huang, S., Liu, H., Cheng, X., Huang, X.-P., Shen, D.-D., Xu, T., Liu, Y.-F., Wang, Y., Guo, J., Jiang, Y., Jiang, H., Melcher, K., Roth, B. L., Zhang, Y., Zhang, C., & Xu, H. E.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 184
- Issue
- 4
- Pages
- 931-942.e18
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3127467109
- Cited by
- 253
- References
- 61
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.